Language:

Tertiary lymphoid structures improve immunotherapy and survival in melanoma

Nature (London), 2020-01, Vol.577 (7791), p.561-565 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;COPYRIGHT 2020 Nature Publishing Group ;Copyright Nature Publishing Group Jan 23, 2020 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-019-1914-8 ;PMID: 31942071

Full text available

Citations Cited by

Actions
1. Add to My Research
2. Remove from My Research
3. E-mail
4. Print
5. Permalink
6. Citation
7. EasyBib
8. EndNote
9. RefWorks
10. Delicious
11. Export RIS
12. Export BibTeX

Title:
Tertiary lymphoid structures improve immunotherapy and survival in melanoma
Author: Cabrita, Rita ; Lauss, Martin ; Sanna, Adriana ; Donia, Marco ; Skaarup Larsen, Mathilde ; Mitra, Shamik ; Johansson, Iva ; Phung, Bengt ; Harbst, Katja ; Vallon-Christersson, Johan ; van Schoiack, Alison ; Lövgren, Kristina ; Warren, Sarah ; Jirström, Karin ; Olsson, Håkan ; Pietras, Kristian ; Ingvar, Christian ; Isaksson, Karolin ; Schadendorf, Dirk ; Schmidt, Henrik ; Bastholt, Lars ; Carneiro, Ana ; Wargo, Jennifer A ; Svane, Inge Marie ; Jönsson, Göran
Subjects: Antigen presentation ; Antigens, CD20 - metabolism ; B cells ; B-Lymphocytes - immunology ; B-Lymphocytes - metabolism ; B7-H1 Antigen - antagonists & inhibitors ; Biomarkers ; Cancer ; Cancer and Oncology ; Cancer och onkologi ; Care and treatment ; CD20 antigen ; CD8 antigen ; CD8-Positive T-Lymphocytes - immunology ; CD8-Positive T-Lymphocytes - metabolism ; Cell survival ; Chemokine CXCL13 - metabolism ; Clinical Medicine ; CXCL13 protein ; CXCR5 protein ; Drug therapy ; Health aspects ; Humans ; Immune checkpoint ; Immune system ; Immunofluorescence ; Immunologic Memory - immunology ; Immunological memory ; Immunology ; Immunotherapy ; Intestinal microflora ; Klinisk medicin ; Lymphatic system ; Lymphocytes ; Lymphocytes B ; Lymphocytes T ; Lymphoid tissue ; Medical and Health Sciences ; Medical research ; Medicin och hälsovetenskap ; Medicine, Experimental ; Melanoma ; Melanoma - genetics ; Melanoma - immunology ; Melanoma - pathology ; Melanoma - therapy ; Memory cells ; Metastases ; Metastasis ; Neoplasm Metastasis - genetics ; Neoplasm Metastasis - pathology ; Patient outcomes ; Patients ; Phenotype ; Phenotypes ; Physiological aspects ; Prognosis ; Programmed Cell Death 1 Receptor - antagonists & inhibitors ; Proteomics ; Receptors, CXCR5 - metabolism ; RNA-Seq ; Single-Cell Analysis ; Spatial data ; Survival ; Survival analysis ; Survival Rate ; T Cell Transcription Factor 1 - metabolism ; T cells ; T-Lymphocytes - immunology ; T-Lymphocytes - metabolism ; Tertiary Lymphoid Structures - genetics ; Tertiary Lymphoid Structures - immunology ; Treatment Outcome ; Tumor Microenvironment - immunology ; Tumors
Is Part Of: Nature (London), 2020-01, Vol.577 (7791), p.561-565
Description: Checkpoint blockade therapies that reactivate tumour-associated T cells can induce durable tumour control and result in the long-term survival of patients with advanced cancers . Current predictive biomarkers for therapy response include high levels of intratumour immunological activity, a high tumour mutational burden and specific characteristics of the gut microbiota . Although the role of T cells in antitumour responses has thoroughly been studied, other immune cells remain insufficiently explored. Here we use clinical samples of metastatic melanomas to investigate the role of B cells in antitumour responses, and find that the co-occurrence of tumour-associated CD8 T cells and CD20 B cells is associated with improved survival, independently of other clinical variables. Immunofluorescence staining of CXCR5 and CXCL13 in combination with CD20 reveals the formation of tertiary lymphoid structures in these CD8 CD20 tumours. We derived a gene signature associated with tertiary lymphoid structures, which predicted clinical outcomes in cohorts of patients treated with immune checkpoint blockade. Furthermore, B-cell-rich tumours were accompanied by increased levels of TCF7 naive and/or memory T cells. This was corroborated by digital spatial-profiling data, in which T cells in tumours without tertiary lymphoid structures had a dysfunctional molecular phenotype. Our results indicate that tertiary lymphoid structures have a key role in the immune microenvironment in melanoma, by conferring distinct T cell phenotypes. Therapeutic strategies to induce the formation of tertiary lymphoid structures should be explored to improve responses to cancer immunotherapy.
Publisher: England: Nature Publishing Group
Language: English
Identifier: ISSN: 0028-0836
EISSN: 1476-4687
DOI: 10.1038/s41586-019-1914-8
PMID: 31942071
Source: ProQuest One Psychology
MEDLINE
ProQuest Central

Back to results list


INSPIRE LIBRARY - TON DUC THANG UNIVERSITY	(84-028) 37 755 057	Feedback
19 Nguyen Huu Tho St. Dist.7, HCM	thuvien@tdtu.edu.vn	Feedback

Tertiary lymphoid structures improve immunotherapy and survival in melanoma

COPYRIGHT 2020 Nature Publishing Group ;COPYRIGHT 2020 Nature Publishing Group ;Copyright Nature Publishing Group Jan 23, 2020 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-019-1914-8 ;PMID: 31942071

Searching Remote Databases, Please Wait